Brief Communication | Published:

Distinct roles of IκB proteins in regulating constitutive NF-κB activity

Nature Cell Biology volume 7, pages 921923 (2005) | Download Citation

Subjects

Abstract

The inhibitor of NF-κB (IκB) family of proteins is believed to regulate NF-κB activity by cytoplasmic sequestration. We show that in cells depleted of IκBα, IκBβ and IκBε proteins, a small fraction of p65 binds DNA and leads to constitutive activation of NF-κB target genes, even without stimulation, whereas most of the p65 remains cytoplasmic. These results indicate that although IκBα, IκBβ and IκBε proteins could be dispensable for cytoplasmic retention of NF-κB, they are essential for preventing NF-κB-dependent gene expression in the basal state. We also show that in the absence of IκBα, IκBβ and IκBε proteins, cytoplasmic retention of NF-κB by other cellular proteins renders the pathway unresponsive to activation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , , & Genes Dev. 9, 2723–2735 (1995).

  2. 2.

    & Genes Dev. 18, 2195–2224 (2004).

  3. 3.

    & Annu. Rev. Immunol. 18, 621–663 (2000).

  4. 4.

    , , & Mol. Cell. Biol. 16, 6477–6485 (1996).

  5. 5.

    , & Mol. Cell. Biol. 17, 5386–5399 (1997).

  6. 6.

    et al. Mol. Cell. Biol. 16, 2341–2349 (1996).

  7. 7.

    , , , & Nature 376, 167–170 (1995).

  8. 8.

    & Nature Rev. Mol. Cell. Biol. 5, 392–401 (2004).

  9. 9.

    , & Mol. Cell. Biol. 18, 2524–2534 (1998).

  10. 10.

    , , & Mol. Cell. Biol. 20, 2269–2284 (2000).

  11. 11.

    , , & J. Biol. Chem. 275, 36441–36449 (2000).

  12. 12.

    & J. Biol. Chem. 278, 556–566 (2003).

  13. 13.

    , , , & Mol. Cell. Biol. 23, 8070–8083 (2003).

  14. 14.

    , , & Proc. Natl Acad. Sci. USA 100, 1844–1848 (2003).

  15. 15.

    et al. J. Immunol. 163, 5994–6005 (1999).

Download references

Acknowledgements

We wish to thank A. Hoffmann and D. Baltimore for sharing unpublished information and for insights into this work. We thank C. Rothlin, O. Singer, G. Ghosh, N. Tonnu and B. Coyne for suggestions and help. V.T. is supported by a career development fellowship from the Leukemia and Lymphoma Society. I.M.V. is an American Cancer Society Professor of Molecular Biology and is supported by grants from the NIH, the Wayne and Gladys Valley Foundation, the Larry L. Hillblom Foundation, Inc., the Lebensfeld Foundation, the Merck Research Laboratories and the H.N. and Frances C. Berger Foundation.

Author information

Author notes

    • Vinay Tergaonkar

    Present address: Institute of Molecular and Cell Biology, 61 Biopolis Drive, 138673, Singapore.

    • Masahito Ikawa

    Present address: Genome information Research Center, Osaka University, 3-1, Osaka 565-0871, Japan.

Affiliations

  1. Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

    • Vinay Tergaonkar
    • , Ricardo G Correa
    •  & Inder M Verma

Authors

  1. Search for Vinay Tergaonkar in:

  2. Search for Ricardo G Correa in:

  3. Search for Masahito Ikawa in:

  4. Search for Inder M Verma in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Inder M Verma.

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    Supplementary figures S1, S2, S3 and Supplementary methods

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/ncb1296

Further reading